乾元浩QYH品牌怎么样 申请店铺

知名兽药禽药品牌，集兽用生物制品及诊断试剂研发/生产/销售/技术服务/投资及进出口贸易为一体的综合型企业，其重大动物疫病疫苗业界较为有名

乾元浩生物股份有限公司（以下简称“乾元浩”）隶属国有大型中央企业，于2004年7月1日正式在国家工商行政管理总局注册成立，注册资金1.28亿元。乾元浩主营兽用生物制品及诊断试剂的生产、销售、研发、技术服务、项目投资及进出口贸易。

乾元浩是农业部指定生产高致病性禽流感、高致病性猪蓝耳病、猪瘟、狂犬病等重大动物疫病疫苗的企业，在国家防控禽流感、口蹄疫等重大动物疫病过程中做出贡献。旗下拥有三个GMP生产基地——南京生物药厂、郑州生物药厂、北京生物药厂，并参股南京梅里亚动物保健有限公司。南京生物药厂可追溯至1931年，是国内兽用生物制品生产企业。郑州生物药厂成立于1949年，在国内实现禽流感疫苗工业化生产。北京生物药厂成立于1988年；南京梅里亚动物保健有限公司是由法国梅里亚集团和乾元浩共同投资组建的高科技合资企业。

乾元浩目前可生产兽用生物制品及诊断试剂近60个品种、200多个规格，年产动物疫苗200多亿羽（头）份。产品国内市场占有率居行业前列。公司产品已出口印尼、埃及、越南、蒙古等多个国家，与非洲、东南亚及周边等国家建立了经贸合作关系。

Qianyuanhao biological Co., Ltd. (hereinafter referred to as "Qianyuanhao") is a well-known brand of veterinary medicine and poultry medicine, a comprehensive enterprise integrating research and development / production / sales / technical services / investment and import and export trade of veterinary biological products and diagnostic reagents. It is well-known in the vaccine industry of major animal diseases. It is a state-owned large-scale central enterprise. It was officially established in the State Administration for Industry and Commerce on July 1, 2004 The Bureau was registered and established with a registered capital of 128 million yuan. Qianyuanhao is mainly engaged in the production, sales, research and development, technical services, project investment and import and export trade of biological products and diagnostic reagents for animal use. Qianyuanhao is an enterprise designated by the Ministry of agriculture to produce vaccines for major animal diseases such as highly pathogenic avian influenza, highly pathogenic swine blue ear disease, swine fever, rabies, etc. it has made contributions to the national prevention and control of avian influenza, foot-and-mouth disease and other major animal diseases. It has three GMP production bases - Nanjing biopharmaceutical factory, Zhengzhou biopharmaceutical factory and Beijing biopharmaceutical factory, and shares in Nanjing Meiya animal health Co., Ltd. Nanjing biopharmaceutical factory can be traced back to 1931. It is a domestic animal biological product manufacturer. Zhengzhou biopharmaceutical factory was founded in 1949, and industrialized production of avian influenza vaccine was realized in China. Beijing biopharmaceutical factory was founded in 1988. Nanjing meiria animal health Co., Ltd. is a high-tech joint venture jointly invested by meiria group of France and Qianyuanhao. At present, Qianyuanhao can produce nearly 60 varieties and more than 200 specifications of animal biological products and diagnostic reagents, with an annual output of more than 20 billion animal vaccines. The domestic market share of products is in the forefront of the industry. The company's products have been exported to Indonesia, Egypt, Vietnam, Mongolia and other countries, and established economic and trade cooperation relations with Africa, Southeast Asia and surrounding countries.

本文链接： https://brand.waitui.com/3fbd45d6f.html 联系电话：01052261000